Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. - Wikidata - wikimedia - TriplyDB

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

http://www.wikidata.org/entity/Q34449273

about

Body size and risk of MS in two cohorts of US women Undernutrition in patients with COPD and its treatment Adiposity measures and oxidative stress among police officers The voltage-gated potassium channel Kv1.3 regulates peripheral insulin sensitivity Exercise training and plasma C-reactive protein and interleukin-6 in elderly people The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer Innate immunity and inflammation in ageing: a key for understanding age-related diseases Relationships between Rodent White Adipose Fat Pads and Human White Adipose Fat Depots Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1 Fortifying the Treatment of Prostate Cancer with Physical Activity Vitamin D and the Promotion of Long-Term Metabolic Health from a Programming Perspective Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases Adipose tissue and adipokines: the association with and application of adipokines in obesity Neuroinflammatory basis of metabolic syndrome Obesity and adipokines: effects on sympathetic overactivity Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection Interaction of differentiated human adipocytes with macrophages leads to trogocytosis and selective IL-6 secretion.Chronic IL-6 Administration Desensitizes IL-6 Response in Liver, Causes Hyperleptinemia and Aggravates Steatosis in Diet-Induced-Obese Mice Mice chronically fed high-fat diet have increased mortality and disturbed immune response in sepsis Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes Obesity-related polymorphisms and their associations with the ability to regulate fat oxidation in obese Europeans: the NUGENOB study Melanocortins induce interleukin 6 gene expression and secretion through melanocortin receptors 2 and 5 in 3T3-L1 adipocytes The endocrine function of adipose tissue: an update Muscle-derived interleukin-6: possible biological effects Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice Inflammation's Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naïve Patients with Bipolar II Disorder Maintaining brain health by monitoring inflammatory processes: a mechanism to promote successful aging Levels and determinants of inflammatory biomarkers in a Swiss population-based sample (CoLaus study)Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression Helicobacter pylori infection and diabetes: is it a myth or fact?Metformin use in children with obesity and normal glucose tolerance--effects on cardiovascular markers and intrahepatic fat.A cross-sectional study of food group intake and C-reactive protein among children.Weight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data?Glucose homeostasis influences the risk of incident knee osteoarthritis: Data from the osteoarthritis initiative.Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study.mRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action.An islet in distress: β cell failure in type 2 diabetes.Circulating markers of inflammation and their link to indices of adiposity Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.

P2860

Q22241653-84806FBC-5D00-4B66-B11D-352D517664BF Q22305600-B3105DD9-08AC-448D-BB0C-73E9A4CE362F Q23917167-0C048003-18E3-4CCD-A549-2501048A4754 Q24624806-A9A3C148-016D-49B2-A361-CC0EEFEF6A6C Q24641995-07954E1A-15DE-4FC2-9276-0875C541CB81 Q24802322-B28EA3EB-0EF9-4948-BAAE-9E24369DF197 Q24814846-5B6884E8-2C90-4241-A317-063EF72984F8 Q26752318-B02AF28F-0E34-4552-A6B9-A33CD251A8BB Q26752511-70476FF0-33BB-415F-BC86-6521BF7FB786 Q26765503-92350AC1-1A86-40E9-B42E-E306C61C4B69 Q26769601-686A3C4D-8AE2-4826-B4CD-B7209B48DDB4 Q26825467-F862FFCB-1DD9-4418-82CF-C2450628BCC1 Q26830052-6C4BBD91-F391-43D1-8E0E-D5A9BB6491E4 Q26852584-719174B5-3B5E-4643-BDEA-6D902114F478 Q27000398-FB44C6EB-7448-4A8E-8937-0ED5883F93D3 Q27317216-95B4BDD8-F364-4195-BF29-BCC3E0BD4374 Q27330460-49A3533F-FBB0-41E3-BA5A-847C7127C3FF Q27336446-1083EDCC-927C-4E05-9D45-4EB32970C2A0 Q27336723-9C79EF1A-A634-4332-B50C-7BC0F9E2EFF2 Q28081672-4C60ED26-BFE1-420E-8B61-DDE61D0F9CE6 Q28218908-4E39635B-D59D-42B6-9FA1-C4B4576AA25C Q28263080-4D632D19-9DA6-48DD-80E5-E26497F68222 Q28270969-37B568C2-92F6-4C8C-A340-80C2928F780B Q28305131-CC573995-F169-43BC-840D-987FDE9BF59D Q28361640-02C93047-9ADE-4D5D-9124-5D328D21A619 Q28385478-3C82787D-B192-4ED0-93C5-B5E0E92E66F4 Q28534387-BB56089E-EC39-4129-84C1-15F219A57E8D Q28730725-0F3856C8-949F-46CC-8A25-3624E15DB061 Q28743795-21C81E88-B541-4908-A06A-D367DDEE5E91 Q29615766-2CEC3655-B6BF-45F8-AFB9-D14241EA41C7 Q30361927-FC509E71-F69F-4A8B-A52D-667FBA85D00A Q30413605-B593BC8E-0F39-4EFF-BAD9-F9490CC80991 Q30491312-ED26C3D4-7092-49CC-8064-014E74C5C49A Q30572730-51E15474-4011-49C2-8736-2B7327DB7926 Q31157312-81B23E0C-E5AA-477A-9579-D94059AECB3A Q33374940-DF58A6DF-55C8-407D-B108-46A8275C5F2B Q33464150-BDE12ED2-CFBD-4875-879C-BF9EBAB2E075 Q33558360-74569BE8-0C3D-49FE-9A49-CDBBE1E9699E Q33575903-EA3E78AF-A0D4-4107-B3BD-1F73D903FD20 Q33580624-67CF0C86-3F7D-4D16-8582-20DBD74C4C59

P2860

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

http://www.wikidata.org/entity/Q34449273

description

1997 nî lūn-bûn

@nan

1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Subcutaneous adipose tissue re ...... ecrosis factor-alpha, in vivo.

@ast

Subcutaneous adipose tissue re ...... ecrosis factor-alpha, in vivo.

@en

Subcutaneous adipose tissue re ...... ecrosis factor-alpha, in vivo.

@nl

type

label

Subcutaneous adipose tissue re ...... ecrosis factor-alpha, in vivo.

@ast

Subcutaneous adipose tissue re ...... ecrosis factor-alpha, in vivo.

@en

Subcutaneous adipose tissue re ...... ecrosis factor-alpha, in vivo.

@nl

prefLabel

Subcutaneous adipose tissue re ...... ecrosis factor-alpha, in vivo.

@ast

Subcutaneous adipose tissue re ...... ecrosis factor-alpha, in vivo.

@en

Subcutaneous adipose tissue re ...... ecrosis factor-alpha, in vivo.

@nl

P1433

Q34449273-095F2360-2E44-47E5-9F08-16C9DEEA24C5

P1476

Q34449273-35BEEAF2-0E56-46EA-B8E1-0CE4689EC110

P2093

Q34449273-14F44F29-C259-4855-866D-6AA043E6BD97

Q34449273-23B653A6-E699-45EE-973D-C14BD3370C44

Q34449273-4D716319-1AC0-4A4C-8F83-A2B1D0284F19

Q34449273-60C2FBDB-21D3-4862-AF88-820CA7E88F6C

Q34449273-79A26F2E-5681-4DB4-86B7-F63225BD7C15

Q34449273-9B282968-7B7F-4D33-95B1-C1FE3AE4B592

Q34449273-B82EB3E0-9A2B-4D4F-BF10-C888792C1244

Q34449273-D2F1D956-F3B5-4EF1-BA69-95D8C87F5727

P304

Q34449273-FE2F97C2-1EC5-4763-95DC-59893757EB34

P31

Q34449273-450D37BB-4BC0-436C-AF6E-C71844DDA07E

P356

Q34449273-D845B0C6-EDC7-407D-A369-AD4BCD4FBDE1

P407

Q34449273-01C3724A-FEDF-4A52-8FED-77402F662E5B

P433

Q34449273-F0583743-A86F-42E8-AE08-51A1C2E3ADAB

P478

Q34449273-6C1C5903-5DE7-4959-ADD9-9D5D47F45D28

P577

Q34449273-7EF6BCA3-C677-40CF-9FFB-79DFE4F6445C

P5875

Q34449273-1C04EA3F-F1CE-410A-81F7-C4D472CB33B2

P698

Q34449273-A43D5EBC-0CCA-47B1-B36E-A9D52887C12B

P921

Q34449273-9ce07d6c-d3ec-4bf5-a5fa-acdac44c7231

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Subcutaneous adipose tissue re ...... ecrosis factor-alpha, in vivo.

@en

P2093

Coppack SW

http://www.w3.org/2001/XMLSchema#string

Goodrick S

http://www.w3.org/2001/XMLSchema#string

Katz DR

http://www.w3.org/2001/XMLSchema#string

Klein S

http://www.w3.org/2001/XMLSchema#string

Miles JM

http://www.w3.org/2001/XMLSchema#string

Mohamed-Ali V

http://www.w3.org/2001/XMLSchema#string

Rawesh A

http://www.w3.org/2001/XMLSchema#string

Yudkin JS

http://www.w3.org/2001/XMLSchema#string

P304

4196-4200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.82.12.4196

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P577

1997-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237796005

http://www.w3.org/2001/XMLSchema#string

P698

9398739

http://www.w3.org/2001/XMLSchema#string

P921